With an aim to reduce its import dependence on China for sourcing drug raw material and spur production in India, the government proposes to offer local manufacturers of active pharmaceutical ingredients (APIs) production and viability-linked incentives up to Rs 10 crore.
from Times of India https://ift.tt/2XYDjjX
Tuesday, 2 June 2020
To cut dependence on China for APIs, Centre offers incentives to desi firms
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment